Nursing care
Oxycodone: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Oxycodone is an oral opioid used for moderate to severe pain, available in immediate- and extended-release forms. The extended-release tablet must never be crushed, chewed or split, because doing so releases the full 12-hour dose immediately and can cause fatal respiratory depression. Confirm the formulation before every dose, since IR and ER tablets can look alike.
Why this drug and not another
Oxycodone is chosen for its reliable oral bioavailability and predictable analgesia, which makes it a mainstay for both acute postoperative pain and chronic cancer or non-cancer pain that needs around-the-clock control. Unlike fentanyl, it does not require a transdermal depot or IV access, so it fits patients who can swallow and need steady dosing without inpatient monitoring equipment.
The existence of both immediate-release and controlled-release formulations lets prescribers match the drug to the pain pattern: IR for breakthrough or short-term pain, ER for baseline chronic pain requiring a stable 12-hour blood level. That dual-formulation design is also exactly where the drug's biggest safety hazard lives.
Administration and timing
Extended-release oxycodone must be swallowed whole. Crushing, chewing or splitting the tablet destroys the matrix that controls release and delivers the entire 12-hour dose at once, which has caused fatal overdoses in patients and in anyone who diverts a crushed tablet for insufflation or injection. Confirm with every patient and every med pass that the tablet is being swallowed intact, and never administer ER oxycodone via a feeding tube unless the specific product is labeled safe for that route.
Immediate-release oxycodone is given every 4 to 6 hours for breakthrough or acute pain, while ER formulations are typically dosed every 12 hours to maintain a steady baseline level. Do not use ER oxycodone as the first opioid a patient has ever received; it is intended for patients already opioid-tolerant, and giving it to an opioid-naive patient risks the same overdose danger as accidental crushing.
Monitoring parameters
Assess respiratory rate and sedation level before each dose and at intervals appropriate to the route and formulation, holding the dose and notifying the provider if respirations fall below the facility's threshold, typically 10 to 12/min. Pain reassessment should follow the drug's expected onset — roughly 30 to 60 minutes for IR, more gradual for ER — so reassessing too early can lead to unnecessary redosing.
Monitor bowel function from the first dose, since opioid-induced constipation is near universal and does not improve with tolerance the way sedation does. In patients on long-term therapy, watch for signs of tolerance or withdrawal at dosing intervals, and monitor renal and hepatic function periodically, since both organs affect oxycodone clearance and accumulation risk.
Adverse effects to report
Respiratory depression and oversedation are the effects to escalate immediately; have naloxone accessible and know the dose may need repeating since oxycodone's duration, especially the ER form, can outlast naloxone's effect. Report hypotension, particularly after the first dose or a dose increase, and any new confusion or unresponsiveness.
Report severe constipation unresponsive to a bowel regimen, urinary retention, and pruritus that suggests histamine release. In patients also taking other CNS depressants, watch closely for additive sedation, and report any signs consistent with accidental ER tablet manipulation, such as an unexpectedly rapid or intense response to what should be a sustained-release dose.
Contraindications and cautions
Avoid oxycodone in significant respiratory depression, and use extreme caution in COPD or sleep apnea, where baseline respiratory reserve is already reduced. ER oxycodone is contraindicated in opioid-naive patients and in acute, mild, or intermittent pain, since its purpose is sustained control in a tolerant patient, not first-line analgesia.
Use caution in hepatic and renal impairment, where drug clearance slows and dose adjustment or interval extension is often needed. Combining oxycodone with other CNS depressants, including benzodiazepines and alcohol, raises the risk of fatal respiratory depression, and this combination requires careful reassessment of whether both drugs are truly necessary.
Teaching points the exam tests
The exam frequently tests whether you catch a patient, caregiver or even a colleague attempting to crush an ER oxycodone tablet for easier swallowing or feeding-tube administration. The correct action is to stop the crushing, confirm the formulation, and contact the pharmacy or provider about an appropriate alternative, since IR tablets or liquid formulations may be substituted.
Also expect scenario questions distinguishing IR from ER dosing schedules, and questions where a patient reports the ER tablet 'doesn't seem to be working' and asks to take it more often — the teaching point is that ER oxycodone should not be adjusted by the patient, and breakthrough pain on a stable ER regimen calls for a separate IR order, not doubling the ER dose.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Can extended-release oxycodone be crushed for a patient who has trouble swallowing?
No. Crushing destroys the extended-release mechanism and releases the full 12-hour dose at once, which can cause fatal respiratory depression. Ask the provider or pharmacist about a liquid or immediate-release alternative instead.
How often is extended-release oxycodone given?
Typically every 12 hours to maintain a steady blood level for chronic pain. It should not be redosed early or adjusted by the patient if pain breaks through.
What's the difference between immediate-release and extended-release oxycodone?
Immediate-release is used for breakthrough or short-term acute pain and is dosed every 4 to 6 hours. Extended-release maintains steady analgesia over 12 hours and is reserved for opioid-tolerant patients with chronic pain.
What vital sign matters most before giving oxycodone?
Respiratory rate, checked before every dose. Hold the dose and notify the provider if it falls below the facility's threshold, usually around 10 to 12 breaths per minute.
Is oxycodone safe for an opioid-naive patient?
Immediate-release oxycodone can be used cautiously with close monitoring, but the extended-release formulation is not appropriate for opioid-naive patients because of its high total dose delivered over 12 hours.
More on pharmacology
Guides on this